220 related articles for article (PubMed ID: 25485910)
21. Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cells.
Nieborowska-Skorska M; Slupianek A; Skorski T
Oncogene; 2000 Aug; 19(36):4117-24. PubMed ID: 10962572
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia.
Pfeifer H; Lange T; Wystub S; Wassmann B; Maier J; Binckebanck A; Giagounidis A; Stelljes M; Schmalzing M; Dührsen U; Wunderle L; Serve H; Brück P; Schmidt A; Hoelzer D; Ottmann OG
Leukemia; 2012 Jul; 26(7):1475-81. PubMed ID: 22230800
[TBL] [Abstract][Full Text] [Related]
23. Recurrent gene mutations detected in canine mast cell tumours by next generation sequencing.
Vozdova M; Kubickova S; Pal K; Fröhlich J; Fictum P; Rubes J
Vet Comp Oncol; 2020 Dec; 18(4):509-518. PubMed ID: 31999054
[TBL] [Abstract][Full Text] [Related]
24. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
[TBL] [Abstract][Full Text] [Related]
25. Rationally designed aberrant kinase-targeted endogenous protein nanomedicine against oncogene mutated/amplified refractory chronic myeloid leukemia.
Retnakumari AP; Hanumanthu PL; Malarvizhi GL; Prabhu R; Sidharthan N; Thampi MV; Menon D; Mony U; Menon K; Keechilat P; Nair S; Koyakutty M
Mol Pharm; 2012 Nov; 9(11):3062-78. PubMed ID: 22971013
[TBL] [Abstract][Full Text] [Related]
26. G protein subunit β1 is an important mediator of the late stage of endochondral ossification.
Ruengsinpinya L; Murakami T; Nakamura E; Takahata Y; Hata K; Nakaminami Y; Okae H; Nishimura R
Biochem Biophys Res Commun; 2020 Nov; 533(1):90-96. PubMed ID: 32928505
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of guanine nucleotide-binding protein beta 1 (GNB1) is associated with worsened prognosis of clearcell renal cell carcinoma and is related to VEGF signaling pathway.
Chen C; Chi H; Min L; Junhua Z
J BUON; 2017; 22(6):1441-1446. PubMed ID: 29332336
[TBL] [Abstract][Full Text] [Related]
28. Refining the phenotype associated with GNB1 mutations: Clinical data on 18 newly identified patients and review of the literature.
Hemati P; Revah-Politi A; Bassan H; Petrovski S; Bilancia CG; Ramsey K; Griffin NG; Bier L; Cho MT; Rosello M; Lynch SA; Colombo S; Weber A; Haug M; Heinzen EL; Sands TT; Narayanan V; Primiano M; Aggarwal VS; Millan F; Sattler-Holtrop SG; Caro-Llopis A; Pillar N; Baker J; Freedman R; Kroes HY; Sacharow S; Stong N; Lapunzina P; Schneider MC; Mendelsohn NJ; Singleton A; Loik Ramey V; Wou K; Kuzminsky A; Monfort S; Weiss M; Doyle S; Iglesias A; Martinez F; Mckenzie F; Orellana C; van Gassen KLI; Palomares M; Bazak L; Lee A; Bircher A; Basel-Vanagaite L; Hafström M; Houge G; ; ; Goldstein DB; Anyane-Yeboa K
Am J Med Genet A; 2018 Nov; 176(11):2259-2275. PubMed ID: 30194818
[TBL] [Abstract][Full Text] [Related]
29. Novel GNB1 de novo mutation in a patient with neurodevelopmental disorder and cutaneous mastocytosis: Clinical report and literature review.
Szczałuba K; Biernacka A; Szymańska K; Gasperowicz P; Kosińska J; Rydzanicz M; Płoski R
Eur J Med Genet; 2018 Mar; 61(3):157-160. PubMed ID: 29174093
[TBL] [Abstract][Full Text] [Related]
30. GNB1 Encephalopathy: Clinical Case Report and Literature Review.
Nasvytis M; Čiauškaitė J; Jurkevičienė G
Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674235
[TBL] [Abstract][Full Text] [Related]
31. Second patient with GNB2-related neurodevelopmental disease: Further evidence for a gene-disease association.
Lansdon LA; Fleming EA; Viso FD; Sullivan BR; Saunders CJ
Eur J Med Genet; 2021 Jul; 64(7):104243. PubMed ID: 33971351
[TBL] [Abstract][Full Text] [Related]
32. Phenotype-genotype correlations in patients with GNB1 gene variants, including the first three reported Japanese patients to exhibit spastic diplegia, dyskinetic quadriplegia, and infantile spasms.
Endo W; Ikemoto S; Togashi N; Miyabayashi T; Nakajima E; Hamano SI; Shibuya M; Sato R; Takezawa Y; Okubo Y; Inui T; Kato M; Sengoku T; Ogata K; Hamanaka K; Mizuguchi T; Miyatake S; Nakashima M; Matsumoto N; Haginoya K
Brain Dev; 2020 Feb; 42(2):199-204. PubMed ID: 31735425
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous mastocytosis in a child with a de novo GNB1 mutation.
Lattanzio K; Larijani M; Treat JR
Pediatr Dermatol; 2022 Mar; 39(2):328-329. PubMed ID: 35119134
[TBL] [Abstract][Full Text] [Related]
34. Atypical clinical course in two patients with GNB1 variants who developed acute encephalopathy.
Tsuji M; Ikeda A; Tsuyusaki Y; Iai M; Kurosawa K; Kosaki K; Goto T
Brain Dev; 2023 Sep; 45(8):462-466. PubMed ID: 37453880
[TBL] [Abstract][Full Text] [Related]
35. Comment on "Cutaneous mastocytosis in a child with a de novo GNB1 mutation".
Ramírez CG; Azaña Defez JM; Clemente SP; Sanz PL; Córdoba SM
Pediatr Dermatol; 2023; 40(6):1164-1165. PubMed ID: 37970691
[No Abstract] [Full Text] [Related]
36. A case report of a novel GNB1 pathogenic variant and the response to deep brain stimulation.
Rožmarić G; Hero M; Rački V; Vuletić V; Chudy D; Peterlin B
Acta Neurol Belg; 2023 Apr; 123(2):603-605. PubMed ID: 35122616
[No Abstract] [Full Text] [Related]
37. Case Report: A Novel
Da Silva JD; Costa MD; Almeida B; Lopes F; Maciel P; Teixeira-Castro A
Front Neurol; 2021; 12():735549. PubMed ID: 34646230
[TBL] [Abstract][Full Text] [Related]
38.
Wang L; Chen S; Shen Y; Si P
Front Pediatr; 2022; 10():993952. PubMed ID: 36324816
[TBL] [Abstract][Full Text] [Related]
39. Fever-Induced and Early Morning Paroxysmal Dyskinesia in a Man With
Galosi S; Pollini L; Nardecchia F; Cellini E; Guerrini R; Leuzzi V
Mov Disord Clin Pract; 2022 Sep; 9(Suppl 2):S41-S43. PubMed ID: 36118517
[No Abstract] [Full Text] [Related]
40. Neurons Are GIRKed in GNB1 Encephalopathy: Unraveling Pathogenic Mechanisms in a Complex Neurodevelopmental Disorder.
Wagnon JL
Epilepsy Curr; 2023; 23(6):381-382. PubMed ID: 38269351
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
